BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30498084)

  • 1. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.
    Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C
    Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis.
    Xing C; Lu XX; Guo PD; Shen T; Zhang S; He XS; Gan WJ; Li XM; Wang JR; Zhao YY; Wu H; Li JM
    Cancer Res; 2016 Jan; 76(1):83-95. PubMed ID: 26669864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmatine induces G2/M phase arrest and mitochondrial-associated pathway apoptosis in colon cancer cells by targeting AURKA.
    Liu X; Zhang Y; Wu S; Xu M; Shen Y; Yu M; Fan J; Wei S; Xu C; Huang L; Zhao H; Li X; Ye X
    Biochem Pharmacol; 2020 May; 175():113933. PubMed ID: 32224138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.
    Wan L; Chen M; Cao J; Dai X; Yin Q; Zhang J; Song SJ; Lu Y; Liu J; Inuzuka H; Katon JM; Berry K; Fung J; Ng C; Liu P; Song MS; Xue L; Bronson RT; Kirschner MW; Cui R; Pandolfi PP; Wei W
    Cancer Discov; 2017 Apr; 7(4):424-441. PubMed ID: 28174173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AURKA destruction is decoupled from its activity at mitotic exit but is essential to suppress interphase activity.
    Abdelbaki A; Akman HB; Poteau M; Grant R; Gavet O; Guarguaglini G; Lindon C
    J Cell Sci; 2020 Jun; 133(12):. PubMed ID: 32393600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of AURKA sensitizes the efficacy of radiation in human colorectal cancer.
    Liu F; Zhang Y; Dong Y; Ning P; Zhang Y; Sun H; Li G
    Life Sci; 2021 Apr; 271():119148. PubMed ID: 33545203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A.
    Sun W; Jin Y; Wei C; Xu Y; Liu W; Zhong J; Zou Z; Lin X; Xiang Y; Chen Y
    Eur J Cancer; 2023 Jul; 188():49-63. PubMed ID: 37196484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting degron motifs in human AURKA required for its targeting by APC/C
    Abdelbaki A; Ascanelli C; Okoye CN; Akman HB; Janson G; Min M; Marcozzi C; Hagting A; Grant R; De Luca M; Asteriti IA; Guarguaglini G; Paiardini A; Lindon C
    Life Sci Alliance; 2023 Feb; 6(2):. PubMed ID: 36450448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma.
    Crawford LJ; Anderson G; Johnston CK; Irvine AE
    Oncotarget; 2016 Oct; 7(43):70481-70493. PubMed ID: 27655696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells.
    Wu C; Lyu J; Yang EJ; Liu Y; Zhang B; Shim JS
    Nat Commun; 2018 Aug; 9(1):3212. PubMed ID: 30097580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2/M cell cycle arrest.
    Jiang Z; Jiang J; Yang H; Ge Z; Wang Q; Zhang L; Wu C; Wang J
    Oncol Rep; 2014 Mar; 31(3):1249-54. PubMed ID: 24452445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRL-3 promotes the proliferation of LoVo cells via the upregulation of KCNN4 channels.
    Lai W; Chen S; Wu H; Guan Y; Liu L; Zeng Y; Zhao H; Jiang J; Chu Z
    Oncol Rep; 2011 Oct; 26(4):909-17. PubMed ID: 21725609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
    J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors.
    Ice RJ; McLaughlin SL; Livengood RH; Culp MV; Eddy ER; Ivanov AV; Pugacheva EN
    Cancer Res; 2013 May; 73(10):3168-80. PubMed ID: 23539442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
    Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
    J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDM2 regulation by AURKA promotes cell survival in gastric cancer.
    Sehdev V; Katsha A; Arras J; Peng D; Soutto M; Ecsedy J; Zaika A; Belkhiri A; El-Rifai W
    Clin Cancer Res; 2014 Jan; 20(1):76-86. PubMed ID: 24240108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
    Wang J; Zhao X; Jin L; Wu G; Yang Y
    Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer.
    Chou CH; Yang NK; Liu TY; Tai SK; Hsu DS; Chen YW; Chen YJ; Chang CC; Tzeng CH; Yang MH
    Cancer Res; 2013 Jan; 73(2):953-66. PubMed ID: 23204235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
    Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
    Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.